Projects per year
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Radiotherapy
Medicine & Life Sciences
Radiation
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Head and Neck Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
radiation therapy
Physics & Astronomy
Hepatocytes
Medicine & Life Sciences
Liver
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1992 2023
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
4/1/18 → 3/31/23
Project: Research project › Research Project
Neoplasm Antigens
Melanoma
Tumor Microenvironment
Immunosuppressive Agents
T-Lymphocytes
Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS)
3/9/18 → 2/28/23
Project: Research project › Research Project--Cooperative Agreements
Acute Radiation Syndrome
Stromal Cells
Cell- and Tissue-Based Therapy
Transplants
Bone Marrow
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries
6/8/17 → 5/31/22
Project: Research project › Research Project--Cooperative Agreements
Acute Radiation Syndrome
Thrombopoietin
Radiation
Bone Marrow
Wounds and Injuries
Research Output 1979 2019
A Quantitative Clinical Decision–Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy
Brodin, N. P., Kabarriti, R., Pankuch, M., Schechter, C. B., Gondi, V., Kalnicki, S., Guha, C., Garg, M. K. & Tome, W. A., Jan 1 2019, (Accepted/In press) In : International Journal of Radiation Oncology Biology Physics.Research output: Contribution to journal › Article
Clinical Decision Support Systems
Proton Therapy
Oropharyngeal Neoplasms
Quality-Adjusted Life Years
Head and Neck Neoplasms
Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1
Ow, T. J., Fulcher, C. D., Thomas, C., Broin, P., López, A., Reyna, D. E., Smith, R. V., Sarta, C., Prystowsky, M. B., Schlecht, N. F., Schiff, B. A., Rosenblatt, G., Belbin, T. J., Harris, T. M., Childs, G. J., Kawachi, N., Guha, C. & Gavathiotis, E., Jan 1 2019, In : Oncotarget. 10, 4, p. 494-510 17 p.Research output: Contribution to journal › Article
Proteins
Cell Line
Inhibitory Concentration 50
Tissue Banks
Therapeutics
Adjuvant Pelvic Radiation "sandwiched" between Paclitaxel/Carboplatin Chemotherapy in Women with Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial
Frimer, M., Miller, E. M., Viswanathan, S., Girda, E., Mehta, K. J., Smith, H. O., Kuo, D. Y-S., Goldberg, G. L. & Einstein, M. H., Nov 1 2018, In : International Journal of Gynecological Cancer. 28, 9, p. 1781-1788 8 p.Research output: Contribution to journal › Article
Carboplatin
Paclitaxel
Radiation
Carcinoma
Drug Therapy